User profiles for Patrick W. Johnson

Patrick Johnson

Other name: Patrick W. Johnson
Senior Data Science Analyst, Digital Innovation Lab, Mayo Clinic Florida
Verified email at mayo.edu
Cited by 3667

Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

…, KA Bruno, SA Klassen, KL Kunze, PW Johnson… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients

…, AJ Clayburn, MR Spiegel, PW Johnson… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19

…, SA Klassen, JR Mills, PW Johnson… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

[PDF][PDF] Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

…, LA Saltzman, JW Senefeld, PW Johnson… - Cancer cell, 2021 - cell.com
The mRNA vaccines BNT162b2 and mRNA-1273 have robust safety and efficacy against
COVID-19 among immunocompetent individuals (Creech et al., 2021). However, many …

Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience

…, JW Senefeld, SA Klassen, JR Mills, PW Johnson… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

[HTML][HTML] The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis

SA Klassen, JW Senefeld, PW Johnson, RE Carter… - Mayo Clinic …, 2021 - Elsevier
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…

Electrocardiogram screening for aortic valve stenosis using artificial intelligence

…, RE Carter, PW Johnson… - European heart …, 2021 - academic.oup.com
Aims Early detection of aortic stenosis (AS) is becoming increasingly important with a better
outcome after aortic valve replacement in asymptomatic severe AS patients and a poor …

[PDF][PDF] Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

…, LA Saltzman, JW Senefeld, PW Johnson… - Cancer cell, 2021 - cell.com
It has been reported that 15%–25% of patients with hematologic malignancies fail to make
anti-spike (anti-S) antibodies in response to full dosing of SARS-CoV-2 mRNA vaccines (…

Artificial intelligence–enabled assessment of the heart rate corrected QT interval using a mobile electrocardiogram device

…, JM Bos, CD Galloway, JB Shreibati, PW Johnson… - Circulation, 2021 - Am Heart Assoc
Background: Heart rate–corrected QT interval (QTc) prolongation, whether secondary to
drugs, genetics including congenital long QT syndrome, and/or systemic diseases including …

[HTML][HTML] Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence

…, JW Senefeld, KA Senese, PW Johnson… - Frontiers in …, 2021 - frontiersin.org
Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus
disease 2019 (COVID-19) and prevent disease progression. Despite global usage, …